{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:59:05Z","timestamp":1777636745613,"version":"3.51.4"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,4,18]],"date-time":"2012-04-18T00:00:00Z","timestamp":1334707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00415-012-6490-x","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T11:38:51Z","timestamp":1334662731000},"page":"2299-2308","source":"Crossref","is-referenced-by-count":32,"title":["A short Scale for Evaluation of Neuropsychiatric Disorders in Parkinson\u2019s Disease: first psychometric approach"],"prefix":"10.1007","volume":"259","author":[{"given":"Pablo","family":"Martinez-Martin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Frades-Payo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ag\u00fcera-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Ayuga-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,18]]},"reference":[{"key":"6490_CR1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"6490_CR2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AHV (2006) Non-motor symptoms in Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245","journal-title":"Lancet Neurol"},{"key":"6490_CR3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G et al (2007) Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting: Study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623\u20131629","journal-title":"Mov Disord"},{"key":"6490_CR4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mds.23462","volume":"26","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Ray Chaudhuri K, on behalf of the NMSS Validation Group (2011) The impact of non-motor symptoms on health-related quality of life of patients with Parkinson\u2019s disease. Mov Disord 26:399\u2013406","journal-title":"Mov Disord"},{"key":"6490_CR5","author":"A Park","year":"2011","unstructured":"Park A, Stacy M (2011) Dopamine-induced nonmotor symptoms of Parkinson\u2019s Disease. Parkinson Dis. doi: 10.4061\/2011\/485063","journal-title":"Parkinson Dis"},{"key":"6490_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AHV (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464\u2013474","journal-title":"Lancet Neurol"},{"key":"6490_CR7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","volume":"21","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P et al (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u2019s disease: the NMSQuest study. Mov Disord 21:916\u2013923","journal-title":"Mov Disord"},{"key":"6490_CR8","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/mds.23826","volume":"26","author":"S Krishnan","year":"2011","unstructured":"Krishnan S, Sarma G, Sarma S, Kishore A (2011) Do nonmotor symptoms in Parkinson\u2019s disease differ from normal aging? Mov Disord 26:2110\u20132113","journal-title":"Mov Disord"},{"key":"6490_CR9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00415-005-0918-5","volume":"252","author":"S Papapetropoulos","year":"2005","unstructured":"Papapetropoulos S, Mash DC (2005) Psychotic symptoms in Parkinson\u2019s disease. From description to etiology. J Neurol 252:753\u2013764","journal-title":"J Neurol"},{"key":"6490_CR10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/mds.23664","volume":"26","author":"D Weintraub","year":"2011","unstructured":"Weintraub D, Burn DJ (2011) Parkinson\u2019s Disease: the quintessential neuropsychiatric disorder. Mov Disord 26:1022\u20131031","journal-title":"Mov Disord"},{"key":"6490_CR11","first-page":"280","volume":"21","author":"G Friedberg","year":"1998","unstructured":"Friedberg G, Zoldan J, Weizman A, Melamed E (1998) Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson\u2019s disease. Clin Neuropharmacol 21:280\u2013284","journal-title":"Clin Neuropharmacol"},{"key":"6490_CR12","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00415-005-0816-x","volume":"252","author":"D Brandstaedter","year":"2005","unstructured":"Brandstaedter D, Spieker S, Ulm G, Siebert U, Eichhorn TE, Krieg JC et al (2005) Development and evaluation of the Parkinson Psychosis Questionnaire: a screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson\u2019s disease. J Neurol 252:1060\u20131066","journal-title":"J Neurol"},{"key":"6490_CR13","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","volume":"22","author":"KR Chaudhuri","year":"2007","unstructured":"Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P et al (2007) The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study. Mov Disord 22:1901\u20131911","journal-title":"Mov Disord"},{"key":"6490_CR14","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/mds.21696","volume":"22","author":"M Visser","year":"2007","unstructured":"Visser M, Verbaan D, van Rooden SM, Stiggelbout AM, Marinus J, Van Hilten JJ (2007) Assessment of psychiatric complications in Parkinson\u2019s disease: the SCOPA-PC. Mov Disord 22:2221\u20132228","journal-title":"Mov Disord"},{"key":"6490_CR15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins G, Fahn S, Martinez-Martin P et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23:2129\u20132170","journal-title":"Mov Disord"},{"key":"6490_CR16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurol.2009.06.003","volume":"165","author":"C Ardouin","year":"2009","unstructured":"Ardouin C, Ch\u00e9reau I, Llorca PM, Lhomm\u00e9e E, Durif F, Pollak P et al (2009) Assessment of hyper- and hypodopaminergic behaviors in Parkinson\u2019s disease. Rev Neurol (Paris) 165:845\u2013856 (Article in French)","journal-title":"Rev Neurol (Paris)"},{"key":"6490_CR17","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.23081","volume":"25","author":"J Viru\u00e9s-Ortega","year":"2010","unstructured":"Viru\u00e9s-Ortega J, Rodriguez-Blazquez C, Micheli F, Carod-Artal FJ, Serrano-Due\u00f1as M, Martinez-Martin P (2010) Cross-cultural evaluation of the modified Parkinson Psychosis Rating Scale across disease stages. Mov Disord 25:1391\u20131398","journal-title":"Mov Disord"},{"key":"6490_CR18","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.21875","volume":"23","author":"HH Fernandez","year":"2008","unstructured":"Fernandez HH, Aarsland D, F\u00e9nelon G, Friedman JH, Marsh L, Tr\u00f6ster AI et al (2008) Scales to assess psychosis in Parkinson\u2019s disease: critique and recommendations. Mov Disord 23:484\u2013500","journal-title":"Mov Disord"},{"key":"6490_CR19","doi-asserted-by":"crossref","first-page":"639","DOI":"10.33588\/rn.3907.2004324","volume":"39","author":"P Martinez-Martin","year":"2004","unstructured":"Martinez-Martin P, Guerrero Diaz MT, Frades-Payo B (2004) Neuropsychological disorders in Parkinson\u2019s disease: evaluating them and their impact on the caregiver. Rev Neurol 39:639\u2013645 (Article in Spanish)","journal-title":"Rev Neurol"},{"key":"6490_CR20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.21355","volume":"22","author":"P Mart\u00ednez-Mart\u00edn","year":"2007","unstructured":"Mart\u00ednez-Mart\u00edn P, Forjaz MJ, Frades-Payo B, Bayes-Rusi\u00f1ol A, Fern\u00e1ndez-Garc\u00eda JM, Benito-Le\u00f3n J et al (2007) Caregiver burden in Parkinson\u2019s disease. Mov Disord 22:924\u2013931","journal-title":"Mov Disord"},{"key":"6490_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427\u2013442","journal-title":"Neurology"},{"key":"6490_CR22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.2003.017509","volume":"75","author":"J Marinus","year":"2004","unstructured":"Marinus J, Visser M, Stiggelbout AM, Martin Rabey J, Mart\u00ednez-Mart\u00edn P, Bonuccelli U et al (2004) A short scale for the assessment of motor impairments and disabilities in Parkinson\u2019s disease: the SPES\/SCOPA. J Neurol Neurosurg Psychiatry 75:388\u2013395","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6490_CR23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jclinepi.2004.09.014","volume":"58","author":"P Mart\u00ednez-Mart\u00edn","year":"2005","unstructured":"Mart\u00ednez-Mart\u00edn P, Benito-Le\u00f3n J, Burguera JA, Castro A, Linazasoro G, Mart\u00ednez-Castrillo JC et al (2005) The SCOPA-Motor Scale for assessment of Parkinson\u2019s disease is a consistent and valid measure. J Clin Epidemiol 58:674\u2013679","journal-title":"J Clin Epidemiol"},{"key":"6490_CR24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mds.20697","volume":"21","author":"P Martinez-Martin","year":"2006","unstructured":"Martinez-Martin P, Forjaz MJ, Cubo E, Frades B, de Pedro Cuesta J, ELEP Project Members (2006) Global versus factor-related impression of severity in Parkinson\u2019s disease: a new clinimetric index (CISI-PD). Mov Disord 21:208\u2013214","journal-title":"Mov Disord"},{"key":"6490_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.22320","volume":"24","author":"P Martinez-Martin","year":"2009","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C C, Forjaz MJ, de Pedro J, on behalf of the Spanish-American Longitudinal PD Patient Study Group (2009) The Clinical Impression of Severity Index for Parkinson\u2019s Disease: international validation study. Mov Disord 24:211\u2013217","journal-title":"Mov Disord"},{"key":"6490_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"6490_CR27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA et al (2007) Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the Movement Disorder Society task force. Mov Disord 22:2314\u20132324","journal-title":"Mov Disord"},{"key":"6490_CR28","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649\u2013655","journal-title":"Gerontologist"},{"key":"6490_CR29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale. Psychol Rep 10:799\u2013812","journal-title":"Psychol Rep"},{"key":"6490_CR30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1532-5415.1992.tb02101.x","volume":"40","author":"DL Sultzer","year":"1992","unstructured":"Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL (1992) Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale. J Am Geriatr Soc 40:549\u2013555","journal-title":"J Am Geriatr Soc"},{"key":"6490_CR31","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308\u20132314","journal-title":"Neurology"},{"key":"6490_CR32","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 25:2649\u20132653","journal-title":"Mov Disord"},{"key":"6490_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01593882","volume":"4","author":"CA McHorney","year":"1995","unstructured":"McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4:293\u2013307","journal-title":"Qual Life Res"},{"key":"6490_CR34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00422218","volume":"2","author":"RD Hays","year":"1993","unstructured":"Hays RD, Anderson R, Revicki D (1993) Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res 2:441\u2013449","journal-title":"Qual Life Res"},{"key":"6490_CR35","first-page":"16","volume":"9","author":"SC Smith","year":"2005","unstructured":"Smith SC, Lamping DL, Banarjee S, Harwood R, Foley B, Smith P et al (2005) Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess 9:16\u201319","journal-title":"Health Technol Assess"},{"key":"6490_CR36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1015291021312","volume":"11","author":"Scientific Advisory Committee of the Medical Outcomes Trust","year":"2002","unstructured":"Scientific Advisory Committee of the Medical Outcomes Trust (2002) Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11:193\u2013205","journal-title":"Qual Life Res"},{"key":"6490_CR37","doi-asserted-by":"crossref","unstructured":"van der Linden FA, Kragt JJ, Klein M, van der Ploeg HM, Polman CH, Uitdehaag BM (2005) Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use. J Neurol Neurosurg Psychiatry 76:1677\u20131681","DOI":"10.1136\/jnnp.2005.065227"},{"key":"6490_CR38","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00005650-197909000-00003","volume":"17","author":"M Eisen","year":"1979","unstructured":"Eisen M, Ware JE Jr, Donald CA, Brook RH (1979) Measuring components of children\u2019s health status. Med Care 17:902\u2013921","journal-title":"Med Care"},{"key":"6490_CR39","first-page":"49","volume-title":"Quality of life and pharmacoeconomics in clinical trials","author":"EF Juniper","year":"1996","unstructured":"Juniper EF, Guyatt GH, Jaeschke R (1996) How to develop and validate a new health-related quality of life instrument. In: Spilker B (ed) Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Lippincott-Raven Publishers, Philadelphia, pp 49\u201356","edition":"2"},{"key":"6490_CR40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 57:289\u2013300","journal-title":"J Roy Stat Soc"},{"key":"6490_CR41","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0895-4356(01)00407-3","volume":"54","author":"DE Beaton","year":"2001","unstructured":"Beaton DE, Bombardier C, Katz JN, Wright JG (2001) A taxonomy for responsiveness. J Clin Epidemiol 54:1204\u20131217","journal-title":"J Clin Epidemiol"},{"key":"6490_CR42","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-4-54","volume":"4","author":"HC Vet de","year":"2006","unstructured":"de Vet HC, Terwee CB, Ostelo RW, Beckerman H, Knol DL, Bouter LM (2006) Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change. Health Qual Life Outcomes 4:54","journal-title":"Health Qual Life Outcomes"},{"key":"6490_CR43","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","volume":"8","author":"LM Shulman","year":"2002","unstructured":"Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Nonrecognition of depression and other non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 8:193\u2013197","journal-title":"Parkinsonism Relat Disord"},{"key":"6490_CR44","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","volume":"57","author":"CG Goetz","year":"2001","unstructured":"Goetz CG, Leurgans S, Pappert EJ, Raman R, Stemer AB (2001) Prospective longitudinal assessment of hallucinations in Parkinson\u2019s disease. Neurology 57:2078\u20132082","journal-title":"Neurology"},{"key":"6490_CR45","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/mds.20474","volume":"20","author":"WG Ondo","year":"2005","unstructured":"Ondo WG, Tintner R, Dat Voung K, Lai D, Ringholz G (2005) Double-blind, placebo-controlled, unforced titration, parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson\u2019s disease. Mov Disord 20:958\u2013963","journal-title":"Mov Disord"},{"key":"6490_CR46","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","volume":"22","author":"A Schrag","year":"2007","unstructured":"Schrag A, Barone P, Brown RG, Leentjens AFG, McDonald WM, Starkstein S et al (2007) Depression rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 22:1077\u20131092","journal-title":"Mov Disord"},{"key":"6490_CR47","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/mds.22229","volume":"23","author":"AF Leentjens","year":"2008","unstructured":"Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE et al (2008) Apathy and anhedonia rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 23:2004\u20132014","journal-title":"Mov Disord"},{"key":"6490_CR48","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/mds.22233","volume":"23","author":"AF Leentjens","year":"2008","unstructured":"Leentjens AF, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE et al (2008) Anxiety rating scales in Parkinson\u2019s disease: critique and recommendations. Mov Disord 23:2015\u20132025","journal-title":"Mov Disord"},{"key":"6490_CR49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/jnnp.61.1.70","volume":"61","author":"AG Boer de","year":"1996","unstructured":"de Boer AG, Wijker W, Speelman JD, de Haes JCJM (1996) Quality of life in patients with Parkinson\u2019s disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 61:70\u201374","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6490_CR50","series-title":"3rd series","first-page":"291","volume-title":"Handbook of Clinical Neurology: Parkinson\u2019s Disease and Related Disorders, Part I","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Cubo E (2007) Scales to measure parkinsonism. In: Koller WC, Melamed E (eds) Handbook of Clinical Neurology: Parkinson\u2019s Disease and Related Disorders, Part I, vol 83., 3rd seriesElsevier, Edinburgh, pp 291\u2013327"},{"key":"6490_CR51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mds.10656","volume":"19","author":"P Mart\u00ednez-Mart\u00edn","year":"2004","unstructured":"Mart\u00ednez-Mart\u00edn P, Benito-Le\u00f3n J, Alonso F, Catal\u00e1n MJ, Pondal M, Zamarbide I (2004) Health-related quality of life evaluation by proxy in Parkinson\u2019s disease: approach using PDQ-8 and EuroQoL-5D. Mov Disord 19:312\u2013318","journal-title":"Mov Disord"},{"key":"6490_CR52","unstructured":"Mack J, Rabins P, Anderson K, Goldstein S, Grill S, Hirsch ES et al (2011) Prevalence of psychotic symptoms in a community-based Parkinson Disease sample. Am J Geriatr Psychiatry. PMID:21617521"},{"key":"6490_CR53","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"AH Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, O\u2019Sullivan JD, Appel S, Lawrence AD et al (2004) Punding in Parkinson\u2019s disease: its relation to the dopamine dysregulation syndrome. Mov Disord 19:397\u2013405","journal-title":"Mov Disord"},{"key":"6490_CR54","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V et al (2010) Impulse control disorders in Parkinson\u2019s disease. Arch Neurol 67:589\u2013595","journal-title":"Arch Neurol"},{"key":"6490_CR55","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/mds.23821","volume":"26","author":"A Djamshidian","year":"2011","unstructured":"Djamshidian A, Cardoso F, Grosset D, Bowden-Jones H, Lees AJ (2011) Pathological gambling in Parkinson\u2019s disease\u2014a review of the literature. Mov Disord 26:1976\u20131984","journal-title":"Mov Disord"},{"key":"6490_CR56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O\u2019Sullivan JD, Turner K, Manson AJ, Lees AJL (2000) Hedonistic homeostatic dysregulation in patients with Parkinson\u2019s disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 68:423\u2013428","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6490_CR57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"D Weintraub","year":"2006","unstructured":"Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE et al (2006) Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 63:969\u2013973","journal-title":"Arch Neurol"},{"key":"6490_CR58","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","volume":"34","author":"C Huang","year":"2007","unstructured":"Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2007) Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease. Neuroimage 34:714\u2013723","journal-title":"Neuroimage"},{"key":"6490_CR59","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707","journal-title":"Mov Disord"},{"key":"6490_CR60","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.parkreldis.2011.05.017","volume":"17","author":"P Martinez-Martin","year":"2011","unstructured":"Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, Serrano-Due\u00f1as M, Carod Artal FJ, Rojo-Abuin JM, Aarsland D (2011) Dementia associated with Parkinson\u2019s Disease: applying the Movement Disorder Society Task Force criteria. Parkinsonism Rel Disord 17:621\u2013624","journal-title":"Parkinsonism Rel Disord"},{"issue":"Suppl 6","key":"6490_CR61","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1002\/mds.10567","volume":"18","author":"W Poewe","year":"2003","unstructured":"Poewe W (2003) Psychosis in Parkinson\u2019s Disease. Mov Disord 18(Suppl 6):S80\u2013S87","journal-title":"Mov Disord"},{"key":"6490_CR62","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00019442-200510000-00003","volume":"13","author":"D Weintraub","year":"2005","unstructured":"Weintraub D, Stern MB (2005) Psychiatric complications in Parkinson disease. Am J Geriatr Psychiatry 13:844\u2013851","journal-title":"Am J Geriatr Psychiatry"},{"key":"6490_CR63","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0895-4356(99)00071-2","volume":"52","author":"KW Wyrwich","year":"1999","unstructured":"Wyrwich KW, Tierney WM, Wolinsky FD (1999) Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol 52:861\u2013873","journal-title":"J Clin Epidemiol"},{"key":"6490_CR64","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jclinepi.2008.10.011","volume":"62","author":"CB Terwee","year":"2009","unstructured":"Terwee CB, Roorda LD, Knol DL, De Boer MR, De Vet HCW (2009) Linking measurement error to minimal important change of patient-reported outcomes. J Clin Epidemiol 62:1062\u20131067","journal-title":"J Clin Epidemiol"},{"key":"6490_CR65","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/A:1013138911638","volume":"10","author":"H Beckerman","year":"2001","unstructured":"Beckerman H, Roebroeck ME, Lankhorst GJ, Becher JG, Bezemer PD, Verbeek ALM (2001) Smallest real difference, a link between reproducibility and responsiveness. Qual Life Res 10:571\u2013578","journal-title":"Qual Life Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6490-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6490-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6490-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T23:00:15Z","timestamp":1742943615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6490-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,18]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["6490"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6490-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,18]]}}}